Financhill
Back

Spyre Therapeutics 10K Form

Buy
59

SYRE
Spyre Therapeutics

Last Price:
30.75
Seasonality Move:
14.19%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive SYRE News And Ratings

See the #1 stock for the next 7 days that we like better than SYRE

SYRE Financial Statistics

Sales & Book Value

Annual Sales: $886K
Cash Flow: $-28.54M
Price / Cash Flow: 0
Annual Sales: $-0.89
Price / Book: 0

Profitability

EPS (TTM): -69.04220
Net Income (TTM): $-364.23M
Gross Margin: --
Return on Equity: 0%
Return on Assets: 0%

Spyre Therapeutics Earnings Forecast

Key Spyre Therapeutics Financial Ratios

  • The Research & Development expenses have been 10,102.03% of Revenue.
  • The Net Earning history of SYRE is -38,238.15% of Total Revenues.
  • Per Share Earnings over the last 10 years have been positive in 5 years.

Spyre Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: SYRE
Website: spyre.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

SYRE Technical Analysis vs Fundamental Analysis

Buy
59
Spyre Therapeutics (SYRE) is a Buy

Is Spyre Therapeutics a Buy or a Sell?